Primary Aldosteronism Market 2018 Key Country Analysis: Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bristol Laboratories Ltd, CMP Pharma., Koninklijke Philips N.V. and others
The adrenal glands within the body produce some essential hormones like aldosterone. This hormone balances the levels of sodium and potassium in the blood. Primary aldosteronism is a medical condition in which the adrenal glands produce high levels of aldosterone, causing the patient to lose potassium and retain sodium. This excess levels of sodium, increases the blood volume and blood pressure. The diagnosis and treatment of primary aldosteronism is important because it increases the risk of the heart diseases and stroke. This has provided the essential background for market growth. Factors such as increasing prevalence of primary aldosteronism and the growing geriatric population are the major drivers for the market growth. According to a study published in the International Journal of Endocrinology and Metabolism in 2016, the prevalence of the primary aldosteronism was estimated to be greater than 5%. Moreover, increasing obese population and rising consumption of alcohol is estimated to fuel the market. According to the World Health Organization, in 2016, approximately 1.9 billion adults aged 18 years or more were overweight. Moreover, it was estimated that out this population more than 650 million were obese. Additionally, rising per capita healthcare expenditure boosts the market growth. However, lack of awareness and risks associated with corrective surgeries like excessive bleeding, infection, anesthesia reaction besides others are estimated to restrain the market growth during the forecast period.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5522
The global primary aldosteronism market is expected to grow at a CAGR of 8.40% during forecast period.
The global primary aldosteronism market is segmented on the basis of type, indications, diagnosis, treatment and end users.
On the basis of type, the market is segmented as Type I, and Type II. On the basis of indications, the market is categorized into heart attack, kidney failure, stroke, and others. On the basis of diagnosis, the market is segmented into blood test, imaging, and others. The blood test segment is sub-segmented into aldosterone profiling, renin profiling, and others. The imaging segment is sub-segmented into computed tomography (CT), positron emission tomography (PET), and others.On the basis of end users, the market is segmented into surgery, aldosterone antagonists, and others. The aldosterone antagonists is sub-m segmented into spironolactone, eplerenone, and others.
America dominates the global primary aldosteronism market owing to a well-developed healthcare sector and a huge patient population. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. According to the Population Reference Bureau, the American geriatric population is projected to double and reach approximately over 98 million by 2060.
Europe is the second largest market for primary aldosteronism, and is followed by Asia Pacific. Availability of funds for research, a huge patient population and government support for research & development are the driving factors for the market within the region. On a regional basis, the market is segmented into Western Europe, and Eastern Europe. The Western Europe leads the market due to the presence of developed economies like Germany, Italy, France, and others. On the other hand, Eastern Europe is estimated to be the fastest growing market.
Asia Pacific is projected to be the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China. According to the Indian Brand Equity Foundation, the Indian healthcare sector is estimated to be one of the fastest growing sectors and is projected to advance at an estimated CAGR of 22.87% from 2015 to 2020 and reach USD 280 billion till 2020.
On the other hand, the Middle East & Africa has the least share in the global primary aldosteronism market due to the presence of weak economies, stringent government policies and lack of healthcare services especially within the African region. A majority of the market within the Middle East and Africa is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure in the region.
Key players for global primary Aldosteronism market
The key players for the global primary aldosteronism market are Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Bristol Laboratories Ltd (England), CMP Pharma. (U.S.), Koninklijke Philips N.V. (The Netherlands), GE Healthcare (U.K), Siemens AG (Germany), Shimadzu Corporation (Japan), Canon Inc. (Japan), and others.
Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/primary-aldosteronism-market-5522
Detailed Table of Contents:
1. Report Prologue
2.2 Scope Of The Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Aldosteronism Market 2018 Key Country Analysis: Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bristol Laboratories Ltd, CMP Pharma., Koninklijke Philips N.V. and others here
News-ID: 1366661 • Views: 698
More Releases from Market Research Future
CAS9 technology Market Projected to Hit USD 6.72 Billion at a 11.30% CAGR by 203 …
Market overview: The overall CAS9 technology industry is expected to grow over the future years because of its significant economic nature and expanding use opportunities. During 2018- 2030, the industry is anticipated to develop at a compound yearly rate of economic development of 11.30 %. Genetic engineering has advanced with the advent of genomics and genetic manipulation using designed nucleases. As a method for genomics, the CAS9 technique is swiftly gaining
Cloud Billing Market Projected to Hit USD 13.23 Billion at a 16.40% CAGR by 2030 …
Market Overview: The value of the Cloud Billing Market is anticipated to be USD 13.23 billion by the year 2030, growing at a CAGR of 16.40% during the period of forecasting from 2020 to 2030. Cloud billing creates invoices using valuable informational data following previously established billing standards. A cloud-based billing feature serves as a conduit for generating consumption invoices. There will be growth in the cloud billing market in the next
Thermal Paper Market Size 2021: Industry Analysis, Share, Segmentation, Price Tr …
Overview The thermal paper market is anticipated to grow rapidly at a CAGR of 4.87% during the forecast period. The global thermal paper market is driven by increased demand for thermal paper for POS application. These factors have helped shape the thermal paper market and are expected to boost the growth. Companies in the thermal paper market could also face challenges such as increasing demand for paperless billing and volatility in
Dry Bulk Shipping Market 2022 , Share, Size, Growth, Top Manufacturers, Segmenta …
Market Overview Market research indicates that the global market of Dry Bulk Shipping Market Revenue is going to reach up to USD 5,400 Million (approx) within the forecast period 2022-2030 with a CAGR of 4%. Get sample copy of report at: https://www.marketresearchfuture.com/sample_request/8308 Dry Bulk Shipping is the transportation of bulk commodities such as grains, iron ore, coal, lumber, sand, gravel, steel products like rods, plates, coils, and others using vessels. According to
More Releases for Primary
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Global Primary Sclerosing Cholangitis Market
The Primary Sclerosing Cholangitis report offers insights into vital aspects like growth,CAGR value, market share and revenue analysis. It evaluates the growth opportunities, threats, market drivers and risks involved. understand the market competition by analyzing the top vendors, with their market profile, revenue, profits, import-export details, and market share. it states the pricing structure, import-export details, supply chain analysis, SWOT analysis to facilitate the key decision-making process. This report helps
Primary Lithium Battery (Primary Lithium Batteries) Industry Analysis by 2025: …
In its recently published report, QY Research has provided unique insights about global Primary Lithium Battery (Primary Lithium Batteries) market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global Primary
Primary Cells And Primary Batteries Market Analysis by Production Capacity, Dyna …
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Primary Cells And Primary Batteries market. Description The Global Primary Cells And Primary Batteries Market report offers a comprehensive evaluation of the Global Primary Cells And Primary Batteries industry. This report evaluates the Global market for " Global Primary Cells And Primary Batteries". The Global Primary Cells
Primary Immunodeficiency Diseases Market: Key Insights
With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market. These companies have been
Global Primary Biliary Cholangitis Treatment Market is Driven by Rise in Inciden …
Primary biliary cholangitis, previously known as primary biliary cirrhosis, is a rare chronic liver disease, primarily characterized by destruction of the bile ducts which transport bile acid out of the liver. Although the primary cause of the disease has not yet been elucidated, research across the world has attributed it to be autoimmune in nature. The progress of this disease results in the harmful accumulation of bile acid, which causes